Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

ZIOPHARM Oncology, Inc. News

Why 2018 will be better for biotech deals than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Here's what you need to know now for Monday, Jan. 22.

Immunotherapy stocks power higher on Celgene-Juno deal

Shares of immunotherapy companies including Ziopharm Oncology and Fate Therapeutics rose early on Monday on the heels of Juno Therapeutics' announced sale to Celgene.

More Immunotherapy Buyouts Likely After Kite Sale

More Immunotherapy Buyouts Likely After Kite Sale

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.

Breaking News

Tesla Stock Slides On Reports of California Layoffs, Office Closure

Tesla has reportedly closed its San Mateo office, and laid off 200 employees, as it begins a wave of cost cuts throughout the carmaker's global operations.

Disney Stock Lower As Board Extends Contract of CEO Bob Chapek

"Bob is the right leader at the right time for The Walt Disney Company, and the board has full confidence in him and his leadership team,' said Disney chair Sue Arnold.

Bed Bath & Beyond Stock Plunges On Q1 Loss, CEO Mark Tritton Exit

"After thorough consideration, the Board determined that it was time for a change in leadership," said independent director Harriet Edelman.

Pinterest Stock Slumps As CEO Ben Silbermann Steps Down To Make Way For Former Google Executive Bill Ready

"I've learned firsthand that it is indeed fun to do the impossible," said co-founder Ben Silbermann. "And with Bill as our CEO, I know that the fun is just getting started."